The New York Yankees are poised to make a surprising move that could divide opinions among fans and experts alike. With the 2025-2026 offseason underway, the Yankees are predicted to sign an injured starting pitcher, Lucas Giolito, who recently played for their bitter rivals, the Boston Red Sox.
But here's the twist: Tim Kelly from Bleacher Report believes the Yankees will offer Giolito a two-year, $43 million contract with a $20 million club option for 2028. This prediction comes as a shock to many, especially after the Yankees missed out on their long-desired Japanese starter, Tatsuya Imai, who signed with the Houston Astros.
Giolito's injury history is a cause for concern. He missed the entire 2024 season due to an internal brace procedure on his right elbow and was unavailable for the 2025 postseason with an elbow injury. Kelly points out that while some teams may be hesitant, the Yankees might be the perfect fit. But is this a risky move for a team already dealing with injuries to key pitchers like Gerrit Cole, Luis Gil, Clark Schmidt, and Carlos Rodón?
Giolito's 2025 performance, post-surgery, was impressive, with a 3.41 ERA and 1.29 WHIP in 145 innings. However, the Yankees' rotation is already injury-prone, and adding another injured pitcher could be a gamble. And this is where it gets controversial—Giolito insists he's healthy and declined a $19 million player option with the Red Sox, seeking a new club. The Yankees, meanwhile, are considering another injury-prone pitcher, Edward Cabrera, via trade.
So, is signing Giolito a bold move or a potential disaster? Could this be the Yankees' secret weapon, or will it backfire? The Yankees' strategy is sure to spark debate, and we want to hear your thoughts. Is this a calculated risk or a recipe for disaster?
